TY - JOUR
KW - Pharmacy And Pharmacology
KW - primary care
KW - Hepatitis
KW - Hepatitis C
KW - Methadone
KW - Intravenous drug addicts
KW - risk behavior
KW - Clinics
KW - Prescription Drugs
KW - Human immunodeficiency virus--HIV
KW - Epidemics
KW - Opioids
KW - Health risk assessment
KW - Treatment Programs
KW - buprenorphine
KW - France
AU - P. Roux
AU - A. Morel
AU - D. Wolfe
AU - P. Carrieri
A1 - 
AD - Aix Marseille Univ., INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France ; Oppelia, Paris, France ; Open Society Institute, New York, USA ; Aix Marseille Univ., INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France
BT - The International journal on drug policy
C5 - Healthcare Disparities; Opioids & Substance Use
CY - Amsterdam
DO - 10.1016/j.drugpo.2019.06.013
JF - The International journal on drug policy
LA - English
M1 - Journal Article
PB - Elsevier Science Ltd
PP - Amsterdam
PY - 2019
SN - 09553959
SP - 91
T1 - Methadone in primary care in France: Using evidence for action against hepatitis C
T2 - The International journal on drug policy
TI - Methadone in primary care in France: Using evidence for action against hepatitis C
U1 - Healthcare Disparities; Opioids & Substance Use
U3 - 10.1016/j.drugpo.2019.06.013
VL - 71
VO - 09553959
Y1 - 2019
Y2 - 09
ER -